BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17904449)

  • 1. Impact of diabetes on the severity of liver disease.
    Hickman IJ; Macdonald GA
    Am J Med; 2007 Oct; 120(10):829-34. PubMed ID: 17904449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
    Trombetta M; Spiazzi G; Zoppini G; Muggeo M
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():24-7. PubMed ID: 16225467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and the liver: developmental perspectives.
    Hoppin AG
    Semin Liver Dis; 2004 Nov; 24(4):381-7. PubMed ID: 15605306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity related complications in children and adolescents].
    Fichna P; Skowrońska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):223-8. PubMed ID: 17020660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic complications of obesity.
    Diehl AM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):57-68. PubMed ID: 20202579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of liver diseases on the development of type 2 diabetes mellitus.
    Hsieh PS; Hsieh YJ
    World J Gastroenterol; 2011 Dec; 17(48):5240-5. PubMed ID: 22219592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of nonalcoholic fatty liver disease: a global perspective.
    Lazo M; Clark JM
    Semin Liver Dis; 2008 Nov; 28(4):339-50. PubMed ID: 18956290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is liver disease a threat to patients with metabolic disorders?
    Marchesini G; Forlani G; Bugianesi E
    Ann Med; 2005; 37(5):333-46. PubMed ID: 16179269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tipping the balance: the pathophysiology of obesity and type 2 diabetes mellitus.
    McKenney RL; Short DK
    Surg Clin North Am; 2011 Dec; 91(6):1139-48, vii. PubMed ID: 22054144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptogenic cirrhosis and NAFLD: are they related?
    Maheshwari A; Thuluvath PJ
    Am J Gastroenterol; 2006 Mar; 101(3):664-8. PubMed ID: 16464222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver cirrhosis in diabetes mellitus; a complication not always recognized].
    Thewissen CM; Tiebosch AT; Kloppenburg WD; Haagsmna EB; Hoogenberg K
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2369-74. PubMed ID: 19055132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alcohol on viral hepatitis and other forms of liver dysfunction.
    Balasubramanian S; Kowdley KV
    Clin Liver Dis; 2005 Feb; 9(1):83-101. PubMed ID: 15763231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obesity in children and adolescents and diabetes].
    Nazim J; Starzyk J
    Przegl Lek; 2009; 66(1-2):96-9. PubMed ID: 19485265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, inflammation, and insulin resistance.
    Shoelson SE; Herrero L; Naaz A
    Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, hepatic metabolism and disease.
    Edmison JM; Kalhan SC; McCullough AJ
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():163-72; discussion 172-6, 259-68. PubMed ID: 19346775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.